Doripenem Injectable (IV) bulk supplier for pharma manufacturers

Doripenem Injectable (Iv) 500 mg, 1 g per vial Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV)

Available Strengths: 500 mg, 1 g per vial

Reference Brands: Doribax(US & EU)

Doripenem inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacterial lysis and death. It offers broad-spectrum activity against resistant gram-negative bacteria, including Pseudomonas. Benefits include rapid, effective bacterial eradication, high tissue penetration, and once-daily dosing, making it ideal for severe, hospital-based infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Doripenem injectable is approved in the EU and US for severe bacterial infections such as pneumonia, intra-abdominal, and urinary tract infections. In the EU, brands like Doribax are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.

Doripenem Injectable (Iv) — third party manufacturing & bulk supply

Doripenem Injectable (Iv) 500 mg, 1 g per vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Doripenem Injectable (Iv) is supplied as Injectable (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Doripenem Injectable (Iv) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Doripenem Injectable (Iv) →

Back to Listing

Frequently Asked Questions

Doripenem Injectable (IV) is listed as Injectable (IV) in 500 mg, 1 g per vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Doripenem Injectable (IV) is referenced against Doribax(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.